199 related articles for article (PubMed ID: 30903201)
1. Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Badmus OO; Olatunji LA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):913-924. PubMed ID: 30903201
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Olufunto BO; Anoka NA; Olufunmilayo OM; Lawrence OA
Environ Toxicol Pharmacol; 2020 Oct; 79():103423. PubMed ID: 32492534
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Adenosine Deaminase and Xanthine Oxidase Activities by Mineralocorticoid and Glucocorticoid Receptor Blockades Restores Renal Antioxidative Barrier in Oral Contraceptive-Treated Dam.
Badmus OO; Areola ED; Benjamin E; Obekpa MA; Adegoke TE; Elijah OE; Imam A; Olajide OJ; Olatunji LA
J Renin Angiotensin Aldosterone Syst; 2021; 2021():9966372. PubMed ID: 34285713
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen-progestin.
Omolekulo TE; Areola ED; Badmus OO; Michael OS; Kim I; Olatunji LA
Can J Physiol Pharmacol; 2018 Nov; 96(11):1092-1103. PubMed ID: 30001502
[TBL] [Abstract][Full Text] [Related]
5. Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.
Omolekulo TE; Michael OS; Olatunji LA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jan; 392(1):103-116. PubMed ID: 30280312
[TBL] [Abstract][Full Text] [Related]
6. l-glutamine supplementation exerts cardio-renal protection in estrogen-progestin oral contraceptive-treated female rats.
Olaniyi KS; Woru Sabinari I; Olatunji LA
Environ Toxicol Pharmacol; 2020 Feb; 74():103305. PubMed ID: 31790957
[TBL] [Abstract][Full Text] [Related]
7. Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid.
Adeyanju OA; Michael OS; Soladoye AO; Olatunji LA
Arch Physiol Biochem; 2020 Jul; 126(3):225-234. PubMed ID: 30318954
[No Abstract] [Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid.
Omolekulo TE; Michael OS; Olatunji LA
Biomed Pharmacother; 2019 Feb; 110():869-877. PubMed ID: 30557836
[TBL] [Abstract][Full Text] [Related]
9. L-glutamine ameliorates adipose-hepatic dysmetabolism in OC-treated female rats.
Olaniyi KS; Olatunji LA
J Endocrinol; 2020 Jul; 246(1):1-12. PubMed ID: 32413841
[TBL] [Abstract][Full Text] [Related]
10. Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
Olaniyi KS; Olatunji LA
Can J Physiol Pharmacol; 2019 Nov; 97(11):1042-1052. PubMed ID: 31336054
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dipeptidyl peptidase-4 averts free fatty acids deposition in the hearts of oral estrogen-progestin contraceptive-induced hyperinsulinemic female rats.
Adegoke TE; Sabinari IW; Areola ED; Ajao F; Asafa OO; Soluoku TK; Bello A; Adesanmi AM; Yusuf SO; Omoleye A; Ayinla MT; Olatunji LA
Can J Physiol Pharmacol; 2021 Dec; 99(12):1316-1323. PubMed ID: 34310895
[TBL] [Abstract][Full Text] [Related]
12. Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats.
Aremu AO; Lilian DC; Olufemi SA; Aderemi OL
J Renin Angiotensin Aldosterone Syst; 2019; 20(4):1470320319895933. PubMed ID: 31856649
[TBL] [Abstract][Full Text] [Related]
13. Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats.
Dangana EO; Michael OS; Omolekulo TE; Areola ED; Olatunji LA
Biomed Pharmacother; 2019 Jan; 109():1417-1427. PubMed ID: 30551393
[TBL] [Abstract][Full Text] [Related]
14. Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Adeyanju OA; Soetan OA; Soladoye AO; Olatunji LA
Can J Physiol Pharmacol; 2018 Jun; 96(6):577-586. PubMed ID: 29400073
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-progestin oral contraceptive and nicotine exposure synergistically confers cardio-renoprotection in female Wistar rats.
Michael OS; Dibia CL; Adeyanju OA; Olaniyi KS; Areola ED; Olatunji LA
Biomed Pharmacother; 2020 Sep; 129():110387. PubMed ID: 32540646
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
Navarro-Zaragoza J; Laorden ML; Milanés MV
Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone causes defective glucose-6-phosphate dehydrogenase dependent antioxidant barrier through endoglin in pregnant and nonpregnant rats.
Badmus OO; Olatunji LA
Can J Physiol Pharmacol; 2020 Oct; 98(10):667-677. PubMed ID: 32259461
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor blockade attenuates disrupted glutathione-dependent antioxidant defense and elevated endoglin in the hearts of pregnant rats exposed to testosterone.
Usman TO; Badmus OO; Kim I; Olatunji LA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):773-784. PubMed ID: 30783718
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus.
McCullers DL; Herman JP
J Neurosci Res; 2001 May; 64(3):277-83. PubMed ID: 11319772
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K
Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
